AbbVie Can't Get Deduction For $1.6B Merger Fee, IRS Says

By Natalie Olivo · April 18, 2024, 6:17 PM EDT

The IRS defended its denial of AbbVie's claimed deduction for a $1.6 billion payment to a biotechnology company over their failed merger, telling the U.S. Tax Court that the pharmaceutical giant...

To view the full article, register now.